JP2002029980A - Estrogenic agent and collagen production rpomoter, fibroblast proliferative agent, food for cosmetological use and skin cosmetic - Google Patents

Estrogenic agent and collagen production rpomoter, fibroblast proliferative agent, food for cosmetological use and skin cosmetic

Info

Publication number
JP2002029980A
JP2002029980A JP2000210936A JP2000210936A JP2002029980A JP 2002029980 A JP2002029980 A JP 2002029980A JP 2000210936 A JP2000210936 A JP 2000210936A JP 2000210936 A JP2000210936 A JP 2000210936A JP 2002029980 A JP2002029980 A JP 2002029980A
Authority
JP
Japan
Prior art keywords
agent
skin
extract
collagen production
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000210936A
Other languages
Japanese (ja)
Other versions
JP4693963B2 (en
Inventor
Yoshihito Kawashima
善仁 川嶋
Naoko Kishida
直子 岸田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruzen Pharmaceutical Co Ltd
Original Assignee
Maruzen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruzen Pharmaceutical Co Ltd filed Critical Maruzen Pharmaceutical Co Ltd
Priority to JP2000210936A priority Critical patent/JP4693963B2/en
Publication of JP2002029980A publication Critical patent/JP2002029980A/en
Application granted granted Critical
Publication of JP4693963B2 publication Critical patent/JP4693963B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a new medicinal agent alternative to conventional moisturizers, serving as an agent capable of effectively preventing the aging of the skin and maintaining both the firmness and glossiness of the skin. SOLUTION: This new medicinal agent, an estrogenic agent, collagen production promoter or fibroblast proliferative agent, is obtained by subjecting the embryos (embyo buds) in the seeds of Nelumbo nucifera Gaertn. belonging to Nymphaea family to extraction with a hydrophilic organic solvent such as methanol, ethanol, 1,3-butylene glycol or glycerol, water or a water-based solvent such as a mixture thereof. The other objective foods for cosmetological use including candies, soft/refreshing drinks and tablets, or skin cosmetics including cream, milky lotions, lotions and pack are obtained by using the above estrogenic agent, collagen production promoter or fibroblast proliferative agent.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明はエストロゲン様作用
剤及びコラーゲン産生促進剤、線維芽細胞増殖作用剤、
美容用食品並びに皮膚化粧料に関する。具体的には、女
性ホルモンの一種であるエストロゲンと同様の作用を有
する新規なエストロゲン様作用剤、皮膚を構成するコラ
ーゲンの産生を促進するコラーゲン産生促進剤、人の皮
膚にある線維芽細胞を活発化させる線維芽細胞増殖作用
剤並びにこれらの薬剤を使用した美容用食品及び皮膚化
粧料に関する。
TECHNICAL FIELD The present invention relates to an estrogen-like agent, a collagen production promoter, a fibroblast proliferation agent,
The present invention relates to cosmetic foods and skin cosmetics. Specifically, a novel estrogen-like agent that has the same action as estrogen, a female hormone, a collagen production promoter that promotes the production of collagen that constitutes the skin, and activates fibroblasts in human skin The present invention relates to a fibroblast growth-promoting agent to be converted into a cosmetic, a cosmetic food and a skin cosmetic using the agent.

【0002】[0002]

【従来の技術】加齢に伴う皮膚老化の一因は、女性ホル
モンの一種であるエストロゲンの分泌が減退することで
ある。そこで、エストロゲンの分泌が衰える更年期以後
の女性に対して、エストロゲンと同様の作用をする物質
を経皮的または経口的に投与することが行われている。
そのためのエストロゲン様作用剤として、従来から、ス
テロイド系エストロゲン、非ステロイド系エストロゲ
ン、フラボン系化合物等が使用されてきた。
2. Description of the Related Art One of the causes of skin aging associated with aging is a decrease in secretion of estrogen, a kind of female hormone. Therefore, a substance having the same action as estrogen is transdermally or orally administered to post-menopausal women in which estrogen secretion declines.
Conventionally, steroidal estrogens, non-steroidal estrogens, flavone compounds and the like have been used as estrogen-like agents for this purpose.

【0003】ここにおいて、皮膚の表皮及び真皮は、表
皮細胞、線維芽細胞及びこれらの細胞の外にあって皮膚
構造を支持するコラーゲン等の細胞外マトリックスによ
り構成されている。
[0003] Here, the epidermis and dermis of the skin are composed of epidermal cells, fibroblasts, and extracellular matrices such as collagen outside these cells and supporting the skin structure.

【0004】若い皮膚においては、線維芽細胞の増殖は
活発であり、線維芽細胞やコラーゲン等の皮膚構成組織
の相互作用が恒常性を保つことにより水分保持、柔軟
性、弾力性等が確保され、肌は外見的にも張りや艶があ
ってみずみずしい状態に維持される。
[0004] In young skin, fibroblasts are actively proliferating, and the interaction of skin constituent tissues such as fibroblasts and collagen maintains homeostasis, thereby securing water retention, flexibility, elasticity, and the like. In addition, the skin is maintained in a fresh and crisp appearance.

【0005】ところが、紫外線の照射、空気の著しい乾
燥、過度の皮膚洗浄等、ある種の外的因子の影響があっ
たり、加齢が進んだりすると、線維芽細胞の増殖が遅く
なり、コラーゲンの産生量も減少する。その結果、皮膚
はその保湿機能や弾力性が低下し、角質は異常剥離を始
め、肌は張りや艶を失い、荒れ、シワ等の老化症状を呈
するようになる。
However, under the influence of certain external factors, such as irradiation with ultraviolet rays, remarkable drying of air, and excessive skin washing, or as aging progresses, the proliferation of fibroblasts slows down, and collagen Production is also reduced. As a result, the skin loses its moisturizing function and elasticity, the keratin begins to peel off abnormally, and the skin loses its tone and luster, becomes rough, and exhibits aging symptoms such as wrinkles.

【0006】このような皮膚の老化を防止・改善するた
めに最も普通に行われているのは、天然保湿因子(NM
F)である糖、アミノ酸、有機酸、ピロリドンカルボン
酸塩、コラーゲン、ヒアルロン酸等のムコ多糖類、グリ
セリン、1,3−ブチレングリコール等の保湿作用のあ
る物質を塗布して皮膚の保湿性を高めることである。し
かしながら、保湿剤は表皮の角質の状態を改善すること
は期待できない。また、皮膚からの水分蒸発を遅くする
ものであるから概して使用感が悪く、長期間使用すると
皮膚障害を起こすことさえある。
[0006] The most commonly used method for preventing and improving such skin aging is the natural moisturizing factor (NM).
F) is a moisturizing substance such as mucopolysaccharides such as sugar, amino acid, organic acid, pyrrolidone carboxylate, collagen, hyaluronic acid, glycerin, 1,3-butylene glycol, etc. to improve skin moisturizing property. It is to raise. However, humectants cannot be expected to improve the keratin condition of the epidermis. In addition, since it slows evaporation of water from the skin, the feeling of use is generally poor and long-term use may even cause skin damage.

【0007】従って、皮膚の老化を効果的に防止し、張
りや艶を失わせないためには、従来の保湿剤では不十分
であり、線維芽細胞の賦活化作用やコラーゲン等の産生
促進作用を有する薬剤を使用するのが好ましい。
Therefore, conventional moisturizers are insufficient to effectively prevent aging of the skin and prevent loss of firmness and luster, and have an effect of activating fibroblasts and promoting the production of collagen and the like. It is preferred to use an agent having

【0008】一方、ハスは古来よりその実は食されてあ
るいは漢方薬として使用されており、その安全性は確立
されている。このハスを用いたものとして、例えば、特
開昭62−51606号公報に、日焼け後のほてり、カ
ミソリまけや肌荒れ等に作用するとして、スイレン科植
物から水や低級アルコールなどの溶媒を用いて抽出され
た抽出物が開示されている。また、ハスの種子の胚芽を
用いたものとしては、特開昭63−66126号公報
に、水や水混和性の有機溶媒などを用いて抽出された抽
出物が血圧降下作用を有するとして、さらには、特開昭
64−90129号公報に、同じくハスの胚芽から水や
低級アルコールなどの溶媒を用いて抽出された抽出物
が、高血圧症などの循環器疾患や気管支喘息などの呼吸
器疾患、不眠症などの中枢神経疾患などに作用を有する
として、それぞれ開示されている。
On the other hand, lotus has been eaten or used as a Chinese medicine since ancient times, and its safety has been established. For example, Japanese Patent Application Laid-Open No. 62-51606 discloses that this lotus is used to extract hot flashes after tanning, razor shade and rough skin, and is extracted from waterlily plants using a solvent such as water or a lower alcohol. The disclosed extract is disclosed. Further, as an example using a lotus seed germ, JP-A-63-66126 discloses that an extract extracted using water or a water-miscible organic solvent has a blood pressure lowering effect. Japanese Patent Application Laid-Open No. 64-90129 discloses that an extract similarly extracted from lotus germ using a solvent such as water or lower alcohol is used for circulatory diseases such as hypertension and respiratory diseases such as bronchial asthma. It is disclosed as having an effect on central nervous diseases such as insomnia.

【0009】しかしながら、ハス(種子)の胚芽につい
ては上記作用・効果が知られているだけであり、皮膚の
老化防止作用等については、知られていなかった。
However, only the above-mentioned effects and effects are known for the germ of the lotus (seed), and the anti-aging effect of the skin and the like are not known.

【0010】[0010]

【発明が解決しようとする課題】そこで、本発明者ら
は、皮膚の老化を効果的に防止し、張りや艶を維持する
ものとして、従来の保湿剤になり変わる新たな薬剤を求
めるべく、鋭意努力したところ、ハス胚芽の抽出物中
に、エストロゲン作用やコラーゲン産生の促進作用並び
に線維芽細胞増殖作用があることを見い出し、本発明を
完成させるに至った。
SUMMARY OF THE INVENTION Accordingly, the present inventors have sought to find a new agent that can be used as a conventional moisturizer to effectively prevent skin aging and maintain firmness and luster. As a result of diligent efforts, the inventors have found that the extract of lotus germ has an estrogen action, a collagen production promoting action, and a fibroblast proliferation action, and completed the present invention.

【0011】[0011]

【課題を解決するための手段】本発明に係るエストロゲ
ン様作用剤及びコラーゲン産生促進剤並びに線維芽細胞
増殖作用剤は、それぞれハス胚芽抽出物からなることを
特徴としている。本発明においては、すいれん科ハス属
のハス(Nelumbo nucifera Gaertn.)の種子中にある胚
(胚芽)が用いられる。胚芽は、通常緑色で棒状をして
おり、採取した種子から取り出し、直ちに乾燥したもの
が好適に用いられる。
Means for Solving the Problems The estrogen-like agent, the collagen production promoter and the fibroblast proliferation agent according to the present invention are each characterized by comprising a lotus germ extract. In the present invention, an embryo (germ) in the seed of a lotus (Nelumbo nucifera Gaertn.) Belonging to the genus Lotus of the convulsive family is used. Embryos are usually green and rod-shaped, and are preferably used after being taken out of the collected seeds and immediately dried.

【0012】ハス胚芽抽出物は、この胚芽を、水やメタ
ノール、エタノール、イソプロパノールなどの各種脂肪
族低級アルコール、1,3−ブチレングリコール、エチ
レングリコール、グリセリンなどの親水性有機溶媒、こ
れら親水性有機溶媒の混合物及びこれらの親水性有機溶
媒と水との混液などの各種水系溶媒を用いて抽出するこ
とにより得られるものである。
[0012] The lotus germ extract is prepared by converting the germ into water, various aliphatic lower alcohols such as methanol, ethanol and isopropanol; hydrophilic organic solvents such as 1,3-butylene glycol, ethylene glycol and glycerin; It is obtained by extraction using various aqueous solvents such as a mixture of solvents and a mixture of these hydrophilic organic solvents and water.

【0013】抽出に際しては得られた胚芽をそのまま用
いることもできるが、抽出効率を高めるため、粉砕して
用いるのが好ましい。また、ヘキサンなどの非水系溶媒
(非極性溶媒)を用いて予め脱脂処理しておくと、不純
物含量が少なくなり、より効果の高い抽出物が得られ
る。
In the extraction, the obtained embryo can be used as it is, but it is preferable to use it after pulverization in order to increase the extraction efficiency. In addition, if the non-aqueous solvent (non-polar solvent) such as hexane is used in advance to perform a degreasing treatment, the content of impurities is reduced, and an extract with higher effect can be obtained.

【0014】抽出は、室温ないし加熱下において、抽出
溶媒に応じて任意の装置を用いて行うことができる。例
えば、抽出溶媒を満たした処理槽に粉砕したハス胚芽を
投入し、ときどき撹拌しながら可溶性成分を溶出させ
る。その後、ろ過して抽出残渣を除去し、抽出液を得る
ことができる。このとき用いる溶媒量は、概ねハス胚芽
に対して重量比で、1:5〜1:20となるように用い
るのがよい。
[0014] The extraction can be carried out at room temperature or under heating using an arbitrary apparatus depending on the extraction solvent. For example, crushed lotus germ is put into a treatment tank filled with an extraction solvent, and a soluble component is eluted with occasional stirring. Thereafter, the residue is removed by filtration to obtain an extract. The amount of the solvent used at this time is preferably used so that the weight ratio is generally 1: 5 to 1:20 with respect to the lotus germ.

【0015】こうして得られた抽出物(液)は、そのま
まエストロゲン様作用剤として、またはコラーゲン産生
促進剤として、あるいは線維芽細胞増殖作用剤として用
いることも出来るが、抽出液を濃縮した濃縮液やさらに
濃縮したエキス状物あるいは、抽出溶媒等を留去した乾
燥物として提供することもできる。
The extract (liquid) thus obtained can be used as it is as an estrogen-like agent, as a collagen production promoter, or as a fibroblast growth-promoting agent. It can also be provided as a concentrated extract or a dried product from which the extraction solvent and the like have been distilled off.

【0016】また、ハス胚芽の抽出物は特有のにおいと
味を有するので、生理活性を低下させない程度に脱臭や
脱色等を目的として精製を行うのが好ましい。もちろ
ん、その使用目的等に応じて、例えば本発明に係る美容
用食品や皮膚化粧料に含有させる場合には、大量に使用
するものではないため、そのまま使用しても実用上差し
支えない。
Since the extract of lotus germ has a peculiar smell and taste, it is preferable to purify the extract for the purpose of deodorizing and decoloring to the extent that physiological activity is not reduced. Of course, depending on the purpose of use, for example, when it is contained in the cosmetic food or skin cosmetic according to the present invention, since it is not used in large quantities, it can be practically used as it is.

【0017】さらに本発明のエストロゲン様作用剤やコ
ラーゲン産生促進剤並びに線維芽細胞増殖作用剤には、
必要に応じて上記抽出物に、保存やその取り扱いを容易
にすべく、ショ糖や乳糖などの各種糖類、たんぱく質や
デンプンなどの賦形剤、その他の任意の助剤を用いるこ
とにしてもよい。また、適宜、製剤化して提供すること
も可能であって、例えば、粉末状、顆粒状、錠剤状など
任意の剤形として提供することも可能なものである。
Further, the estrogenic agent, collagen production promoter and fibroblast proliferation agent of the present invention include:
If necessary, the extract may be made to use various sugars such as sucrose and lactose, excipients such as protein and starch, and other optional auxiliaries in order to facilitate storage and handling thereof. . In addition, it can be provided in the form of an appropriate formulation, and can be provided as an arbitrary dosage form such as a powder, a granule, and a tablet.

【0018】これらのエストロゲン様作用剤やコラーゲ
ン産生促進剤並びに線維芽細胞増殖作用剤は、任意の食
品に添加することにより、あるいはこれらを主成分とし
た栄養補助食品などの美容用食品として、経口的に活用
することができる。添加可能な食品には、例えば、各種
の清涼飲料水や果汁飲料、和洋菓子、乳製品その他の畜
産加工品、果実加工品、野菜加工品、穀物の加工品、水
産加工品、調味料、ビタミンなどを主成分としたいわゆ
る各種の健康食品などの多くの飲食品が挙げられる。ま
た、栄養補助食品としても、例えば、液剤の形態のもの
や錠剤などの形態のものとして提供することもできる。
この場合の添加率は、添加対象である美容用食品の一般
的な摂取量を考慮して、液状、固形状など抽出物の形態
によっても異なるが、概ね通常成人1日当たりのハス胚
芽抽出物摂取量として約1〜1000mg、原料である
ハス胚芽乾燥物に換算して、概ね4〜1200mgにな
るように添加するのが適当である。
These estrogen-like agents, collagen production promoters, and fibroblast proliferation agents can be orally added to any food or as a cosmetic food such as a dietary supplement containing them as a main component. It can be used in a practical way. Foods that can be added include, for example, various soft drinks and juice drinks, Japanese and Western confections, dairy products and other livestock processed products, fruit processed products, vegetable processed products, processed cereal products, processed marine products, seasonings, vitamins Many foods and drinks such as so-called various health foods mainly composed of such as foods. Also, as a dietary supplement, for example, it can be provided in the form of a liquid preparation or in the form of a tablet.
In this case, the addition rate varies depending on the form of the extract such as liquid or solid in consideration of the general intake of the cosmetic food to be added. It is suitable to add about 1 to 1000 mg in terms of amount, which is about 4 to 1200 mg in terms of dry material of lotus germ as a raw material.

【0019】また、ハス胚芽抽出物の作用を最も効果的
に発揮させるためには、各種の皮膚化粧料に配合するこ
とである。配合対象として適当な皮膚化粧料は、例え
ば、軟膏、クリーム、乳液、ローション、パック、入浴
剤等であり、この場合の配合量として、ハス胚芽抽出物
として概ね0.01〜10重量%、原料であるハス胚芽
乾燥物換算として、概ね0.04〜40%になるように
添加するのが適当である。
In order to exhibit the action of the lotus germ extract most effectively, it must be mixed with various skin cosmetics. Suitable skin cosmetics to be blended are, for example, ointments, creams, emulsions, lotions, packs, bath preparations and the like. In this case, the blending amount is about 0.01 to 10% by weight as a lotus germ extract, It is appropriate to add so as to be about 0.04 to 40% in terms of dry lotus germ.

【0020】なお、本発明に係る美容用食品や皮膚化粧
料には、これらのエストロゲン様作用,コラーゲン産生
促進作用あるいは線維芽細胞増殖作用のいずれかを妨げ
ない限り、これらの美容用食品や皮膚化粧料の製造に通
常用いられる各種の原材料を用いることができるのは言
うまでもない。
The cosmetic foods and skin cosmetics according to the present invention include these cosmetic foods and skin cosmetics as long as any of these estrogenic effects, collagen production promoting effects and fibroblast proliferation effects are not hindered. It goes without saying that various raw materials usually used for the production of cosmetics can be used.

【0021】[0021]

【実施例】次に、本発明の実施例であるエストロゲン様
作用剤やコラーゲン産生促進剤並びに線維芽細胞増殖作
用剤並びに本発明の製剤例である美容用食品及び皮膚化
粧料を示し、さらに本発明について詳細に説明する。
EXAMPLES Next, examples of the present invention, estrogen-like agents, collagen production promoters and fibroblast proliferation agents, and cosmetic preparations and skin cosmetics as preparation examples of the present invention will be described. The invention will be described in detail.

【0022】(実施例1)ハス胚芽の粗砕物300gを
表1に示す抽出溶媒2000mlにそれぞれ投入し、ゆ
るく撹拌しながら70℃で3時間抽出した。その後、ろ
過して得たろ液を40℃で減圧下に濃縮した後、さらに
減圧乾燥機で乾燥して、粉末状のハス胚芽抽出物である
エストロゲン様作用剤、コラーゲン産生促進作用剤、線
維芽細胞増殖作用剤を得た。その収量を表1に示す。
(Example 1) 300 g of a crude lotus germ was put into each of 2000 ml of extraction solvents shown in Table 1, and extracted at 70 ° C for 3 hours with gentle stirring. Thereafter, the filtrate obtained by filtration is concentrated at 40 ° C. under reduced pressure, and further dried by a reduced-pressure drier to obtain a powdery lotus germ extract, estrogen-like agent, collagen production promoting agent, fibroblast. A cell growth agent was obtained. The yield is shown in Table 1.

【0023】[0023]

【表1】 [Table 1]

【0024】(実施例2)ハス胚芽の粗砕物300g
を、1,3−ブチレングリコールと水の混液(容量比
1:1)2000mlに投入し、撹拌しながら80℃で
3時間抽出した。その後、ろ過して液体状のハス胚芽抽
出物であるエストロゲン様作用剤、コラーゲン産生促進
作用剤、線維芽細胞増殖作用剤、1440mlを得た。
このものの固形分濃度は、4.0重量%であった。な
お、固形分濃度は、当該抽出物の少量を取り、蒸発乾固
させて求めた(以下同様)。
Example 2 300 g of crushed lotus germ
Was poured into 2000 ml of a mixture of 1,3-butylene glycol and water (volume ratio 1: 1), and extracted at 80 ° C. for 3 hours with stirring. Thereafter, the mixture was filtered to obtain 1440 ml of an estrogen-like agent, a collagen production promoting agent, and a fibroblast proliferation agent, which are liquid lotus germ extracts.
This had a solid content of 4.0% by weight. The solid content concentration was determined by taking a small amount of the extract and evaporating it to dryness (the same applies hereinafter).

【0025】(実施例3)抽出溶媒をグリセリンと水の
混液(容量比1:1)を用いた他は、実施例2と同様に
して、液体状のハス胚芽抽出物1540mlを得た。こ
のものの固形分濃度は、3.5重量%であった。
Example 3 1540 ml of a liquid lotus germ extract was obtained in the same manner as in Example 2 except that a mixed solution of glycerin and water (volume ratio 1: 1) was used as an extraction solvent. This had a solid content of 3.5% by weight.

【0026】(実施例4)抽出溶媒をプロピレングリコ
ールと水の混液(容量比1:1)2000mlを用いた
他は、実施例2と同様にして、液体状のハス胚芽抽出物
1540mlを得た。このものの固形分濃度は、3.3
重量%であった。
Example 4 1540 ml of a liquid lotus germ extract was obtained in the same manner as in Example 2 except that 2,000 ml of a mixed solution of propylene glycol and water (volume ratio 1: 1) was used as the extraction solvent. . Its solids concentration is 3.3
% By weight.

【0027】次に、上記実施例1ないし実施例4で得た
各種エストロゲン様作用剤、コラーゲン産生促進作用
剤、線維芽細胞増殖作用剤を用いて、本発明に係る皮膚
化粧料及び美容用食品を各種作製した。 (製剤例1) 〔乳液 100ml中〕 ハス胚芽エタノール・水混液(1:1)抽出物 1.0g グリチルレチン酸ステアリル 0.2g セチルアルコール 0.5g アスコルビン酸リン酸エステルマグネシウム 3.0g ミツロウ 2.0g オレイン酸ポリオキシエチレンソルビタン(10E.O.) 1.0g モノステアリン酸グリセリル 1.0g ヒアルロン酸 0.1g プロピレングリコール 5.0g オウゴン抽出液 1.0g エンドウ種子抽出物 1.0g エタノール 3.0g パラオキシ安息香酸メチル 0.3g 香料 0.03g 精製水 残 量 上記成分分量を取り、常法に従って本発明に係る皮膚化
粧料である乳液を作製した。
Next, using the various estrogen-like agents, collagen production promoting agents and fibroblast proliferation agents obtained in Examples 1 to 4, the skin cosmetics and cosmetic foods according to the present invention were used. Were prepared in various ways. (Formulation Example 1) [Emulsion 100 ml] Lotus germ ethanol / water mixture (1: 1) extract 1.0 g Stearyl glycyrrhetinate 0.2 g Cetyl alcohol 0.5 g Magnesium ascorbate 3.0 g Beeswax 2.0 g Polyoxyethylene sorbitan oleate (10E.O.) 1.0 g Glyceryl monostearate 1.0 g Hyaluronic acid 0.1 g Propylene glycol 5.0 g Ogon extract 1.0 g Pea seed extract 1.0 g Ethanol 3.0 g Paraoxy Methyl benzoate 0.3 g Fragrance 0.03 g Remaining amount of purified water The above component amounts were taken to prepare an emulsion, which is a skin cosmetic according to the present invention, according to a conventional method.

【0028】 (製剤例2) 〔乳液 100ml中〕 ハス胚芽エタノール抽出物 0.1g ハス胚芽 1,3−ブチレングリコール・水混液(1:1)抽出物 1.0g ホホバオイル 4.0g オリーブオイル 2.0g スクワラン 2.0g セタノール 2.0g 酢酸トコフェロール 0.2g モノステアリン酸グリセリル 2.0g ポリオキシエチレンセチルエーテル(20E.O.) 2.5g オレイン酸ポリオキシエチレンソルビタン(20E.O.) 2.0g 1,3−ブチレングリコール 3.0g パラオキシ安息香酸メチル 0.15g シラカバ樹皮抽出物 0.5g 油溶性甘草エキス 0.05g ケイ皮抽出物 0.5g 香料 0.05g 精製水 残 量 上記成分分量を取り、常法に従って本発明に係る皮膚化
粧料である乳液を作製した。
(Formulation Example 2) [Emulsion 100 ml] Lotus germ ethanol extract 0.1 g Lotus germ 1,3-butylene glycol / water mixture (1: 1) extract 1.0 g Jojoba oil 4.0 g olive oil 2 1.0 g Squalane 2.0 g Cetanol 2.0 g Tocopherol acetate 0.2 g Glyceryl monostearate 2.0 g Polyoxyethylene cetyl ether (20 EO) 2.5 g Polyoxyethylene sorbitan oleate (20 EO) 0 g 1,3-butylene glycol 3.0 g methyl paraoxybenzoate 0.15 g birch bark extract 0.5 g oil-soluble licorice extract 0.05 g cinnabar extract 0.5 g flavoring 0.05 g purified water balance Then, an emulsion, which is a skin cosmetic according to the present invention, was prepared according to a conventional method.

【0029】 (製剤例3) 〔化粧水 100ml中〕 ハス胚芽水抽出物 0.2g ハス胚芽 1,3−ブチレングリコール・水混液(1:1)抽出物 2.0g グリセリン 3.0g 1,3−ブチレングリコール 3.0g オレイン酸ポリオキシエチレンソルビタン(20E.O.) 0.5g パラオキシ安息香酸メチル 0.15g クエン酸 0.1g クエン酸ナトリウム 0.1g グリチルリチン酸ジカリウム 0.3g リンデン抽出物 0.5g ビワ抽出物 0.5g 酵母エキス 0.3g ヒアルロン酸水溶液(固形分1%) 3.0g 香料 0.05g 精製水 残 量 上記成分分量を取り、常法に従って本発明に係る皮膚化
粧料である化粧水を作製した。
(Formulation Example 3) [In 100 ml of lotion] Lotus germ water extract 0.2 g Lotus germ 1,3-butylene glycol / water mixture (1: 1) extract 2.0 g glycerin 3.0 g 1,3 -Butylene glycol 3.0 g polyoxyethylene sorbitan oleate (20E.O.) 0.5 g methyl paraoxybenzoate 0.15 g citric acid 0.1 g sodium citrate 0.1 g dipotassium glycyrrhizinate 0.3 g lindane extract 0.0 5 g Loquat extract 0.5 g Yeast extract 0.3 g Hyaluronic acid aqueous solution (solid content 1%) 3.0 g Fragrance 0.05 g Purified water Remaining amount The amount of the above components is taken, and is a skin cosmetic according to the present invention according to a conventional method. A lotion was prepared.

【0030】 (製剤例4) 〔クリーム 100g中〕 ハス胚芽エタノール抽出物 0.1g ハス胚芽 1,3−ブチレングリコール・水混液(1:1)抽出物 1.0g ニンジン抽出液 0.2g ジユ抽出物 0.5g トルメンチラ抽出物 0.5g 加水分解コンキオリン 0.1g 流動パラフィン 5.0g 小麦セラミド 0.1g サラシミツロウ 4.0g セタノール 3.0g スクワラン 10.0g ラノリン 2.0g ステアリン酸 1.0g オレイン酸ポリオキシエチレンソルビタン(20E.O.) 1.5g モノステアリン酸グリセリル 3.0g 1,3−ブチレングリコール 6.0g パラオキシ安息香酸メチル 1.5g 香料 0.1g 精製水 残 量 上記成分分量を取り、常法に従って本発明に係る皮膚化
粧料であるW/O型のクリームを作製した。
(Formulation Example 4) [In 100 g of cream] Lotus germ ethanol extract 0.1 g Lotus germ 1,3-butylene glycol / water mixture (1: 1) extract 1.0 g Carrot extract 0.2 g Extract 0.5 g Tormentilla extract 0.5 g Hydrolyzed conchiolin 0.1 g Liquid paraffin 5.0 g Wheat ceramide 0.1 g Salami beeswax 4.0 g Cetanol 3.0 g Squalane 10.0 g Lanolin 2.0 g Stearic acid 1.0 g Oleic acid Polyoxyethylene sorbitan (20E.O.) 1.5 g Glyceryl monostearate 3.0 g 1,3-butylene glycol 6.0 g Methyl parahydroxybenzoate 1.5 g Perfume 0.1 g Residual water According to a conventional method, a W / O type cream, which is a skin cosmetic according to the present invention, is prepared. It was.

【0031】 (製剤例5) 〔パック 100g中〕 ハス胚芽 1,3−ブチレングリコール・水混液(1:1)抽出物 5.0g ポリビニルアルコール 15.0g プラセンタエキス 1.0g アスコルビン酸 0.02g プエラリアエキス 0.2g オトリギソウ抽出物 1.0g ポリエチレングリコール 3.0g プロピレングリコール 7.0g エタノール 10.0g パラオキシ安息香酸メチル 0.05g 香料 0.05g 精製水 残 量 上記成分分量を取り、常法に従って本発明に係る皮膚化
粧料であるパックを作製した。
(Formulation Example 5) [In 100 g of pack] Lotus germ 1,3-butylene glycol / water mixture (1: 1) extract 5.0 g Polyvinyl alcohol 15.0 g Placenta extract 1.0 g Ascorbic acid 0.02 g Pueraria Extract 0.2 g Potato trifoliatum extract 1.0 g Polyethylene glycol 3.0 g Propylene glycol 7.0 g Ethanol 10.0 g Methyl parahydroxybenzoate 0.05 g Perfume 0.05 g Residual water A pack as the skin cosmetic according to was prepared.

【0032】 (製剤例6) 〔錠剤状美容用食品〕 ハス胚芽 エタノール・水混液(1:1)抽出物 100(重量部) コラーゲン 30 ムコ多糖・タンパク(コンドロイチン) 10 ヒアルロン酸 1 月桃葉茎抽出物 33 黒米抽出物(ポリフェノールを含む) 33 甘草抽出物(グリチルリチンを含む) 10 ミルク蛋白加水分解物 (アミノ酸、低分子ペプチドを含む) 10 ビタミンB群混合粉末(全ビタミンB群を含む) 4 ビタミンC 10 粉糖(ショ糖) 47 グリセリン脂肪酸エステル 12 上記成分分量を取り、常法に従って本発明に係る美容用
食品である錠剤状の健康・栄養補助食品を製造した。
(Formulation Example 6) [Tablet-shaped cosmetic food] Lotus germ Ethanol / water mixture (1: 1) extract 100 (parts by weight) Collagen 30 Mucopolysaccharide / protein (chondroitin) 10 Hyaluronic acid Products 33 Black rice extract (including polyphenols) 33 Licorice extract (including glycyrrhizin) 10 Milk protein hydrolyzate (including amino acids and low molecular weight peptides) 10 Vitamin B group mixed powder (including all vitamin B groups) 4 Vitamin C 10 Powdered sugar (sucrose) 47 Glycerin fatty acid ester 12 The above component amounts were taken, and a tablet-shaped health and nutritional supplement, which is a cosmetic food according to the present invention, was produced according to a conventional method.

【0033】 (製剤例7) 〔顆粒状美容用食品〕 ハス胚芽水抽出物 200(重量部) 真珠蛋白加水分解物(各種アミノ酸、ペプチドを含む) 15 シルク蛋白加水分解物 15 大豆イソフラボン 10 紫米抽出物(ポリフェノールを含む) 100 赤ワインエキスパウダー(プロシアニジンを含む) 30 酵母エキス (グルタチオン、核酸、アミノ酸、ビタミンを含む) 10 ザクロ種子抽出物 10 小麦胚芽抽出物 (ビタミン、クロム、セレン、モリブデンを含む) 10 DNA 30 ビートオリゴ糖 1060 ステビア抽出物 10 上記成分分量を取り、常法に従って本発明に係る美容用
食品である顆粒状の健康・栄養補助食品を製造した。
(Formulation Example 7) [Granular cosmetic food] Lotus germ water extract 200 (parts by weight) Pearl protein hydrolyzate (including various amino acids and peptides) 15 Silk protein hydrolyzate 15 Soy isoflavone 10 Purple rice Extract (including polyphenols) 100 Red wine extract powder (including procyanidin) 30 Yeast extract (including glutathione, nucleic acids, amino acids, and vitamins) 10 Pomegranate seed extract 10 Wheat germ extract (including vitamins, chromium, selenium, and molybdenum) 10) DNA 30 Beet oligosaccharide 1060 Stevia extract 10 The above component amounts were taken, and a granular health and nutritional supplement, which is a cosmetic food according to the present invention, was produced according to a conventional method.

【0034】 (製剤例8) 〔カプセル状美容用食品〕 ハス胚芽 エタノール・水混液(1:1)抽出物 50(重量部) セラミド 30 リン脂質(レシチン) 10 ビタミンE(トコフェロール) 17 マルチカロチン (α及びβカロチン、ルテイン、リコペン) 10 赤米抽出物(シクロアルテノールエステルを含む) 33 オクタコサノール 1 植物ステロール 5 シソの実油(α−リノレン酸を含む) 20 精製魚油(DHA、EPAを含む) 20 ごま油(リグナン化合物を含む) 20 オリーブ油 10 大豆、なたね混合油 62 グリセリン脂肪酸エステル 12 上記成分分量を取り、常法に従ってゼラチンカプセル化
し、本発明に係る美容用食品であるカプセル状の健康・
栄養補助食品を製造した。
(Formulation Example 8) [Capsule-shaped cosmetic food] Lotus germ Ethanol / water mixture (1: 1) extract 50 (parts by weight) Ceramide 30 Phospholipid (lecithin) 10 Vitamin E (tocopherol) 17 Multicarotene ( α and β carotene, lutein, lycopene 10 Red rice extract (including cycloartenol ester) 33 Octacosanol 1 Plant sterol 5 Perilla oil (including α-linolenic acid) 20 Refined fish oil (including DHA, EPA) REFERENCE SIGNS LIST 20 Sesame oil (including lignan compound) 20 Olive oil 10 Soybean and rapeseed mixed oil 62 Glycerin fatty acid ester 12 Take the above component amounts, gelatin capsule according to a conventional method, and obtain capsule-shaped health and beauty food according to the present invention.
Dietary supplements were manufactured.

【0035】 (製剤例9) 〔清涼飲料水状美容用食品 100重量部中〕 ハス胚芽水抽出物 1(重量部) ローヤルゼリー 3 水溶性コラーゲン 8 ハトムギエキス 1 高麗ニンジンエキス(サポニンを含む) 1 プラセンタエキス 1 プエラリアエキス(フラボノイドを含む) 1 パープルヤムエキス 1 オリゴ糖 5 ショ糖 10 プルーン果汁 2 ザクロ果汁 5 グレープフルーツ果汁 10 ビタミンC 1 グレープフルーツフレーバー 0.7 水 残 量 上記成分分量を取り、撹拌溶解して、本発明に係る美容
用食品である清涼飲料水状の健康・栄養補助食品を製造
した。
(Preparation Example 9) [100 parts by weight of soft drink water-based cosmetic food] Lotus germ water extract 1 (parts by weight) Royal jelly 3 Water-soluble collagen 8 Barley extract 1 Ginseng extract (including saponin) 1 Placenta Extract 1 Pueraria extract (including flavonoids) 1 Purple yam extract 1 Oligosaccharide 5 Sucrose 10 Prune juice 2 Pomegranate juice 5 Grapefruit juice 10 Vitamin C 1 Grapefruit flavor 0.7 Water residue Take the above component amounts, stir and dissolve A soft drink-like health / dietary supplement, which is a cosmetic food according to the present invention, was produced.

【0036】 (製剤例10) 〔キャンディ状美容用食品〕 ハス胚芽 エタノール・水混液(1:1)抽出物 2(重量部) 水あめ 30 甘草エキス 3 甜茶エキス 1 ブルーベリーエキス(アントシアンを含む) 1 緑茶エキス(植物ポリフェノールを含む) 3 ストロベリー1/5濃縮果汁 1 赤キャベツ色素 0.05 レモン果汁 0.5 水 5 上記成分分量を取り、常法に従って本発明に係る美容用
食品であるキャンディ状の健康・栄養補助食品を製造し
た。
(Preparation Example 10) [Candy-like beauty food] Lotus germ Ethanol / water mixture (1: 1) extract 2 (parts by weight) Mizuna 30 Licorice extract 3 Tengcha extract 1 Blueberry extract (including anthocyan) 1 Green tea Extract (including plant polyphenols) 3 Strawberry 1/5 concentrated juice 1 Red cabbage pigment 0.05 Lemon juice 0.5 Water 5 Take the above component amounts and take a candy-like health that is a cosmetic food according to the present invention according to a conventional method. -Made dietary supplements.

【0037】(効果試験) 〔エストロゲン様作用〕上記実施例1〜4で得た各種ハ
ス胚芽抽出物について、エストロゲン依存性細胞の増殖
に対する影響を調べるThomasらの方法(In Vitr
o Cell. Dev.Biol. 28A,595−602,199
2)に従って、エストロゲン様作用を調べた。その結果
を表2に示す。なお、水を用いたコントロール値を10
0として示す。
(Effect test) [Estrogen-like action] The method of Thomas et al. (In Vitr) for examining the effect of various Lotus germ extracts obtained in Examples 1 to 4 on the growth of estrogen-dependent cells was examined.
o Cell. Dev. Biol. 28A, 595-602, 199
According to 2), the estrogenic effect was examined. Table 2 shows the results. The control value using water was 10
Shown as 0.

【0038】[0038]

【表2】 [Table 2]

【0039】〔コラーゲン産生促進作用〕上記実施例1
〜4で得た各抽出物について、Websterらの方法(Anal.
Biochem.,Vol96,220,1979)に従って、各抽出物を添加
した培地で培養した線維芽細胞によって産生されたコラ
ーゲン量を測定した。一方、各抽出物を添加しない培地
で産生された放射活性を測定し、このコラーゲン量を1
00とした場合のコラーゲン産生量割合を求めた。以下
に具体的な試験方法を示し、その結果を表3に示す。 試験法:ヒトの線維芽細胞をプレートに播種し、37
℃、5%二酸化炭素下、2種類の試料添加培地(試料濃
度:200ppm及び50ppm)で数日間培養した
後、β−アミノプロピオニトリルと[3H]−プロリン
とを添加し、更に24時間培養した。当該培養液全体に
ペプシン/酢酸溶液を加えて4℃下で16時間消化し、
次いでこの消化液にキャリアーを加えて、0.7M食塩
水で沈殿させ、さらに中性条件下で再溶解させて、4.
2M食塩水で再沈殿させた。得られた沈殿物を20v/
v%エタノールで洗浄した後、その沈殿物の放射活性を
測定した。
[Collagen production promoting action]
Each of the extracts obtained in (1) to (4) was analyzed by the method of Webster et al. (Anal.
Biochem., Vol 96, 220, 1979), the amount of collagen produced by fibroblasts cultured in a medium to which each extract was added was measured. On the other hand, the radioactivity produced in the medium to which each extract was not added was measured, and this collagen amount was reduced to 1
The collagen production ratio when the value was set to 00 was determined. Specific test methods are shown below, and the results are shown in Table 3. Test method: Human fibroblasts were seeded on a plate and
After culturing in two types of sample-added media (sample concentration: 200 ppm and 50 ppm) for several days at 5 ° C. and 5% carbon dioxide, β-aminopropionitrile and [ 3 H] -proline were added, and further 24 hours Cultured. A pepsin / acetic acid solution was added to the whole culture solution and digested at 4 ° C. for 16 hours.
Next, a carrier was added to the digested solution, precipitated with 0.7 M saline, and redissolved under neutral conditions.
Reprecipitated with 2M saline. 20 v /
After washing with v% ethanol, the radioactivity of the precipitate was measured.

【0040】[0040]

【表3】 [Table 3]

【0041】〔線維芽細胞増殖作用〕上記実施例1〜4
で得た各種ハス胚芽抽出物について、多田らによるMT
T法(J.Immunol.Medhods.93,157,1986)に従
い、ヒト正常新生児皮膚線維芽細胞(NBIRGB)を
用いて線維芽細胞増殖作用を測定した。その結果を表4
に示す。なお、水を用いたコントロール値を100とし
て示す。
[Proliferation of fibroblasts] The above Examples 1-4
The various lotus germ extracts obtained in
According to the T method (J. Immunol. Medhods. 93, 157, 1986), the fibroblast proliferation activity was measured using human normal neonatal skin fibroblasts (NBIRGB). Table 4 shows the results.
Shown in The control value using water is shown as 100.

【0042】[0042]

【表4】 (評価結果)表2ないし表4に示すように、水やエタノ
ール、イソプロパノールと水の混液、1,3−ブチレン
グリコールと水の混液など各種水系溶媒を用いたハス胚
芽抽出物には、それぞれ良好なエストロゲン様作用、コ
ラーゲン産生促進作用並びに線維芽細胞増殖作用が認め
られた。
[Table 4] (Evaluation results) As shown in Tables 2 to 4, the lotus germ extracts using various water-based solvents such as water, ethanol, a mixed solution of isopropanol and water, and a mixed solution of 1,3-butylene glycol and water are excellent respectively. An estrogenic effect, a collagen production promoting effect and a fibroblast proliferation effect were observed.

【0043】〔肌荒れ改善効果〕次に上記製剤例1に示
す乳液について、下記の評価試験を行った。なお、比較
例として、ハス胚芽抽出物を含まない乳液を作製し、こ
れを用いた。 ・被験者:22〜43歳の健常な多数の女性の中から、
下記評価基準に従って評点1又は2に該当する肌荒れと
判断された者20名を被験者として選定した。 ・塗布試験:各被験者に、顔の右半分製剤例1に示す乳
液を、左半分には比較例である乳液を、朝夕各1回、そ
の適量を30日間塗布してもらった。 ・評価:塗布試験終了後、シルフロ(Flexicl Developm
ents Ltd 製)によるレプリカ法を用いて、顔のレプリ
カを取り、倍率50倍の光学顕微鏡で皮紋の状態及び角
質剥離状態を観察し、下記の評価基準に従って肌の状態
を判定した。その判定結果を表5に示す。
[Effect of Improving Skin Roughness] Next, the following evaluation test was performed on the emulsion shown in Formulation Example 1 above. As a comparative example, an emulsion containing no lotus germ extract was prepared and used.・ Subject: From a large number of healthy women aged 22 to 43 years,
According to the following evaluation criteria, 20 persons judged to have rough skin corresponding to the score 1 or 2 were selected as subjects. Application test: Each subject was asked to apply an appropriate amount of the emulsion shown in Formulation Example 1 on the right half of the face and the emulsion of the comparative example once on the left half for 30 days in the morning and evening.・ Evaluation: After application test, Sylflo (Flexicl Developm
A replica of the face was taken using a replica method manufactured by ents Ltd., and the skin crest state and exfoliation state were observed with an optical microscope at a magnification of 50 times, and the skin state was determined according to the following evaluation criteria. Table 5 shows the results of the determination.

【0044】判定基準 評 点 1:皮溝・皮丘が消え、広範囲の角質がめくれている。
(肌荒れ状態) 2:皮溝・皮丘が不鮮明。角質が部分的にめくれてい
る。(肌荒れ状態) 3:皮溝・皮丘は認められるが平坦である。(普通肌) 4:皮溝・皮丘が鮮明である。(比較的美しい肌) 5:皮溝・皮丘が極めて鮮明で整っている。(美しい
肌)
Judgment Criteria Score 1: Skin crevices and crusts have disappeared, and a wide range of keratin has been turned over.
(Rough skin condition) 2: Skin grooves / skins are unclear. The keratin is partially turned up. (Rough skin condition) 3: Skin grooves / skins are recognized but flat. (Normal skin) 4: Skin grooves and skin ridges are clear. (Relatively beautiful skin) 5: The skin sulcus / skin is extremely clear and tidy. (Beautiful skin)

【0045】[0045]

【表5】 [Table 5]

【0046】表5に示すように、本発明の製剤例である
乳液を塗布した領域においては、比較例である乳液を塗
布した場合に比べ、顕著に肌荒れが改善されたことが分
かる。
As shown in Table 5, it can be seen that in the area where the emulsion of the present invention was applied, the skin roughness was remarkably improved as compared with the case where the emulsion of the comparative example was applied.

【0047】[0047]

【発明の効果】本発明によれば、安全性が高く、エスト
ロゲンと同様の作用を有する新規なエストロゲン様作用
剤、皮膚を構成するコラーゲンの産生を促進するコラー
ゲン産生促進剤、人の皮膚にある線維芽細胞を活発化さ
せる線維芽細胞増殖作用剤を提供できる。これらを美容
用食品や皮膚化粧料に適用することにより、皮膚の老化
を効果的に防止し、張りや艶の維持に大きく貢献でき
る。
Industrial Applicability According to the present invention, a novel estrogen-like agent having high safety and an action similar to estrogen, a collagen production promoter for promoting the production of collagen constituting skin, and a human skin An agent for promoting fibroblast proliferation that activates fibroblasts can be provided. By applying these to cosmetic foods and skin cosmetics, aging of the skin can be effectively prevented, and it can greatly contribute to maintaining tension and luster.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 43/00 105 A61P 43/00 105 111 111 Fターム(参考) 4B018 MD61 ME10 ME14 4C083 AA032 AA082 AA111 AA112 AA122 AB052 AC012 AC022 AC072 AC102 AC122 AC182 AC242 AC392 AC402 AC482 AD042 AD332 AD532 AD642 AD662 CC02 CC05 DD31 EE12 4C088 AB39 AC04 CA03 ZA91 ZB21 ZC03 ZC11 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI theme coat ゛ (reference) A61P 43/00 105 A61P 43/00 105 111 111 111 F term (reference) 4B018 MD61 ME10 ME14 4C083 AA032 AA082 AA111 AA112 AA122 AB052 AC012 AC022 AC072 AC102 AC122 AC182 AC242 AC392 AC402 AC482 AD042 AD332 AD532 AD642 AD662 CC02 CC05 DD31 EE12 4C088 AB39 AC04 CA03 ZA91 ZB21 ZC03 ZC11

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 ハス胚芽抽出物からなることを特徴とす
るエストロゲン様作用剤。
1. An estrogen-like agent comprising a lotus germ extract.
【請求項2】 ハス胚芽抽出物からなることを特徴とす
るコラーゲン産生促進剤。
2. A collagen production promoter comprising a lotus germ extract.
【請求項3】 ハス胚芽抽出物からなることを特徴とす
る線維芽細胞増殖作用剤。
3. A fibroblast growth-promoting agent comprising a lotus germ extract.
【請求項4】 請求項1記載のエストロゲン様作用剤及
び/又は請求項2記載のコラーゲン産生促進剤及び/又
は請求項3記載の線維芽細胞増殖作用剤を含有すること
を特徴とする美容用食品。
4. A cosmetic composition comprising the estrogen-like agent according to claim 1 and / or the collagen production promoter according to claim 2 and / or the fibroblast proliferation agent according to claim 3. Food.
【請求項5】 請求項1記載のエストロゲン様作用剤及
び/又は請求項2記載のコラーゲン産生促進剤及び/又
は請求項3記載の線維芽細胞増殖作用剤を含有すること
を特徴とする皮膚化粧料。
5. A skin cosmetic comprising the estrogen-like agent according to claim 1 and / or the collagen production promoter according to claim 2 and / or the fibroblast proliferation agent according to claim 3. Fees.
JP2000210936A 2000-07-12 2000-07-12 Estrogen-like agent, collagen production promoter, and fibroblast proliferating agent Expired - Lifetime JP4693963B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000210936A JP4693963B2 (en) 2000-07-12 2000-07-12 Estrogen-like agent, collagen production promoter, and fibroblast proliferating agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000210936A JP4693963B2 (en) 2000-07-12 2000-07-12 Estrogen-like agent, collagen production promoter, and fibroblast proliferating agent

Publications (2)

Publication Number Publication Date
JP2002029980A true JP2002029980A (en) 2002-01-29
JP4693963B2 JP4693963B2 (en) 2011-06-01

Family

ID=18707129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000210936A Expired - Lifetime JP4693963B2 (en) 2000-07-12 2000-07-12 Estrogen-like agent, collagen production promoter, and fibroblast proliferating agent

Country Status (1)

Country Link
JP (1) JP4693963B2 (en)

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002068993A (en) * 2000-08-30 2002-03-08 Maruzen Pharmaceut Co Ltd Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic
JP2004229611A (en) * 2003-01-31 2004-08-19 J-Oil Mills Inc Anti-uv food composition
WO2005042555A1 (en) * 2003-10-30 2005-05-12 Meiji Seika Kaisha, Ltd. Tyrosinase activity inhibitor and ameliorant for facial blood flow
JP2005298489A (en) * 2004-03-15 2005-10-27 Kyoei Kagaku Kogyo Kk Cosmetic
JP2008017815A (en) * 2006-07-14 2008-01-31 Nippon Meat Packers Inc Anti-menopausal syndrome food
EP1781309A4 (en) * 2004-06-09 2008-08-06 Purimed Co Ltd Nelumbinis semen extract for preventing and treating ischemic heart disease and pharmaceutical composition and health food containing the same
WO2006107745A3 (en) * 2005-04-01 2008-12-31 Bionovo Inc Composition for treatment of menopause
US7504117B2 (en) 2003-08-28 2009-03-17 Purimed Co., Ltd. Extract of Nelumbinis Semen for the treatment of depression
JP2009170570A (en) * 2008-01-15 2009-07-30 Elpida Memory Inc Wiring substrate of semiconductor device, semiconductor device, electronic apparatus and mother board
JP2009296998A (en) * 2008-06-17 2009-12-24 Com Institute:Kk Food composition
JP2010043088A (en) * 2004-03-15 2010-02-25 Kyoei Kagaku Kogyo Kk Cosmetic product
US7700136B2 (en) 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
US7799802B2 (en) 2004-08-03 2010-09-21 Institstute of Oriental Medical Science Inc. Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
JP2011020965A (en) * 2009-07-17 2011-02-03 Maruzen Pharmaceut Co Ltd Cosmetic kit, and method of makeup
US8092841B2 (en) 2007-08-08 2012-01-10 Bionovo, Inc. Estrogenic extracts of Ligustrum lucidum ait. of the oleaceae family and uses thereof
JP2012041276A (en) * 2010-08-12 2012-03-01 Maruzen Pharmaceut Co Ltd Carbonylation inhibitor of protein, or transparency improver of skin
US8197868B2 (en) 2007-11-19 2012-06-12 Bionovo, Inc. Process of making purified extract of Scutellaria barbata D. Don
JP2012176945A (en) * 2011-02-02 2012-09-13 Maruzen Pharmaceut Co Ltd Joint function improver and food and drink
WO2012147619A1 (en) * 2011-04-27 2012-11-01 キッコーマン株式会社 Blood glucose level increase inhibitor
CN102835709A (en) * 2011-06-24 2012-12-26 株式会社资生堂 Beauty beverage containing collagen
US8512961B2 (en) 2007-11-19 2013-08-20 Bionovo, Inc. Methods of detecting and treatment of cancers using Scutellaria barbata extract
CN103494286A (en) * 2013-10-17 2014-01-08 漳州片仔癀药业股份有限公司 Drink with moisturizing and skin whitening functions and method for manufacturing drink
CN103535724A (en) * 2013-10-17 2014-01-29 漳州片仔癀药业股份有限公司 Health-care food with moisturizing and whitening functions
JP2014172896A (en) * 2013-03-12 2014-09-22 Kyoei Kagaku Kogyo Kk Hair composition
US9155770B2 (en) 2007-09-07 2015-10-13 Bionovo, Inc. Estrogenic extracts of Scuttelaria barbata D. don of the labiatae family and uses thereof
US9220740B2 (en) 2007-09-07 2015-12-29 Bionovo, Inc. Estrogenic extracts of Astragalus membranaceus fisch. bge. var. mongolicus bge. of the Leguminosae family and uses thereof
US9339523B2 (en) 2007-09-07 2016-05-17 Bionovo, Inc. Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae family and uses thereof
JP2016216365A (en) * 2015-05-14 2016-12-22 医療環境テクノ株式会社 Pharmaceutical composition for repairing and activating skin and method for producing the same
JP2019182753A (en) * 2018-04-03 2019-10-24 丸善製薬株式会社 Endo180 production promoter
JP2020120597A (en) * 2019-01-30 2020-08-13 株式会社常磐植物化学研究所 Skin care agent and food composition for skin care
WO2024128147A1 (en) * 2022-12-16 2024-06-20 株式会社漢方医科学研究所 Composition, agent, and methods for producing same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101837960B1 (en) 2015-09-18 2018-03-13 유씨엘 주식회사 Anti-wrinkle composition comprising extracts of nelumbo nucifera roots, and willow or propolis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925348A (en) * 1996-02-23 1999-07-20 Medical Doctor's Research Institute, Inc. Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin
CN1254755A (en) * 1998-11-21 2000-05-31 乌鲁木齐恭喜酒厂 Lotus seed wine and its production technology

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925348A (en) * 1996-02-23 1999-07-20 Medical Doctor's Research Institute, Inc. Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin
CN1254755A (en) * 1998-11-21 2000-05-31 乌鲁木齐恭喜酒厂 Lotus seed wine and its production technology

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002068993A (en) * 2000-08-30 2002-03-08 Maruzen Pharmaceut Co Ltd Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic
JP2004229611A (en) * 2003-01-31 2004-08-19 J-Oil Mills Inc Anti-uv food composition
US7504117B2 (en) 2003-08-28 2009-03-17 Purimed Co., Ltd. Extract of Nelumbinis Semen for the treatment of depression
WO2005042555A1 (en) * 2003-10-30 2005-05-12 Meiji Seika Kaisha, Ltd. Tyrosinase activity inhibitor and ameliorant for facial blood flow
JPWO2005042555A1 (en) * 2003-10-30 2007-05-10 明治製菓株式会社 Tyrosinase activity inhibitor and facial blood flow improving agent
US7863248B2 (en) 2003-10-30 2011-01-04 Meiji Seika Kaisha, Ltd. Tyrosinase activity inhibitor and ameliorant for facial blood flow
JP4593474B2 (en) * 2003-10-30 2010-12-08 明治製菓株式会社 Tyrosinase activity inhibitor and facial blood flow improving agent
JP2010043088A (en) * 2004-03-15 2010-02-25 Kyoei Kagaku Kogyo Kk Cosmetic product
JP2005298489A (en) * 2004-03-15 2005-10-27 Kyoei Kagaku Kogyo Kk Cosmetic
JP4563225B2 (en) * 2004-03-15 2010-10-13 共栄化学工業株式会社 Cosmetics
EP1781309A4 (en) * 2004-06-09 2008-08-06 Purimed Co Ltd Nelumbinis semen extract for preventing and treating ischemic heart disease and pharmaceutical composition and health food containing the same
US7799802B2 (en) 2004-08-03 2010-09-21 Institstute of Oriental Medical Science Inc. Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
US9446086B2 (en) * 2005-04-01 2016-09-20 Bionovo, Inc. Composition for treatment of menopause
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
WO2006107745A3 (en) * 2005-04-01 2008-12-31 Bionovo Inc Composition for treatment of menopause
US8110228B2 (en) 2005-04-01 2012-02-07 Bionovo, Inc. Composition for treatment of menopause
US20120107344A1 (en) * 2005-04-01 2012-05-03 Bionovo, Inc. Composition for treatment of menopause
US7700136B2 (en) 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
JP2008017815A (en) * 2006-07-14 2008-01-31 Nippon Meat Packers Inc Anti-menopausal syndrome food
US8092841B2 (en) 2007-08-08 2012-01-10 Bionovo, Inc. Estrogenic extracts of Ligustrum lucidum ait. of the oleaceae family and uses thereof
US9339523B2 (en) 2007-09-07 2016-05-17 Bionovo, Inc. Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae family and uses thereof
US9220740B2 (en) 2007-09-07 2015-12-29 Bionovo, Inc. Estrogenic extracts of Astragalus membranaceus fisch. bge. var. mongolicus bge. of the Leguminosae family and uses thereof
US9155770B2 (en) 2007-09-07 2015-10-13 Bionovo, Inc. Estrogenic extracts of Scuttelaria barbata D. don of the labiatae family and uses thereof
US8512961B2 (en) 2007-11-19 2013-08-20 Bionovo, Inc. Methods of detecting and treatment of cancers using Scutellaria barbata extract
US8197868B2 (en) 2007-11-19 2012-06-12 Bionovo, Inc. Process of making purified extract of Scutellaria barbata D. Don
JP2009170570A (en) * 2008-01-15 2009-07-30 Elpida Memory Inc Wiring substrate of semiconductor device, semiconductor device, electronic apparatus and mother board
JP2009296998A (en) * 2008-06-17 2009-12-24 Com Institute:Kk Food composition
JP2011020965A (en) * 2009-07-17 2011-02-03 Maruzen Pharmaceut Co Ltd Cosmetic kit, and method of makeup
JP2012041276A (en) * 2010-08-12 2012-03-01 Maruzen Pharmaceut Co Ltd Carbonylation inhibitor of protein, or transparency improver of skin
JP2012176945A (en) * 2011-02-02 2012-09-13 Maruzen Pharmaceut Co Ltd Joint function improver and food and drink
WO2012147619A1 (en) * 2011-04-27 2012-11-01 キッコーマン株式会社 Blood glucose level increase inhibitor
CN102835709A (en) * 2011-06-24 2012-12-26 株式会社资生堂 Beauty beverage containing collagen
JP2014172896A (en) * 2013-03-12 2014-09-22 Kyoei Kagaku Kogyo Kk Hair composition
CN103494286A (en) * 2013-10-17 2014-01-08 漳州片仔癀药业股份有限公司 Drink with moisturizing and skin whitening functions and method for manufacturing drink
CN103535724A (en) * 2013-10-17 2014-01-29 漳州片仔癀药业股份有限公司 Health-care food with moisturizing and whitening functions
JP2016216365A (en) * 2015-05-14 2016-12-22 医療環境テクノ株式会社 Pharmaceutical composition for repairing and activating skin and method for producing the same
JP2019182753A (en) * 2018-04-03 2019-10-24 丸善製薬株式会社 Endo180 production promoter
JP2020120597A (en) * 2019-01-30 2020-08-13 株式会社常磐植物化学研究所 Skin care agent and food composition for skin care
WO2024128147A1 (en) * 2022-12-16 2024-06-20 株式会社漢方医科学研究所 Composition, agent, and methods for producing same

Also Published As

Publication number Publication date
JP4693963B2 (en) 2011-06-01

Similar Documents

Publication Publication Date Title
JP2002029980A (en) Estrogenic agent and collagen production rpomoter, fibroblast proliferative agent, food for cosmetological use and skin cosmetic
CN102781421B (en) Extrait du fruit de schizandra sphenanthera et compositions cosmetiques, dermatologiques et nutraceutiques le comprenant
JP5220761B2 (en) Composition for dermatological use comprising quinoa grain extract
JP4658348B2 (en) Collagen production promoter, collagenase inhibitor, fibroblast proliferation agent, elastase inhibitor, estrogen-like agent, and skin cosmetics
KR100855199B1 (en) Functional foods containing sphingoglycolipids and a process for its production
JP4658290B2 (en) Fibroblast proliferating agent, cosmetic food and drink, and skin cosmetics
JP2002003393A (en) Fibroblast growth agent, food and drink for beauty culture and skin cosmetic
JP3608078B2 (en) Collagen production promoter, estrogenic agent, skin cosmetic and beauty food
JP2004131431A (en) Composition for preventing or ameliorating ultraviolet damage
JP5024978B2 (en) Antioxidant
JP4703832B2 (en) Collagen production promoter, estrogen-like agent, collagenase inhibitor, skin cosmetic and food and drink
JP3933511B2 (en) Skin cosmetics and beauty food and drink
JP2002068993A (en) Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic
JP2011055837A (en) Food and drink for beautification
JP4672269B2 (en) Anti-aging agent, platelet aggregation inhibitor, antioxidant, antiallergic agent, skin cosmetics and food and drink
JP2003137801A (en) Collagen production promoter, collagenase inhibitor, fibroblast cell-propagating agent, skin cosmetic material and food or beverage for cosmetic use
JP2002302452A (en) Histamine separation inhibitor, cyclic amp phosphodiesterase inhibitor, active oxygen scavenger and radical scavenger
JP4722595B2 (en) Anti-inflammatory agents, antioxidants and whitening agents, and skin cosmetics
JP3827581B2 (en) Skin cosmetics and beauty food and drink
KR102106440B1 (en) Composition for improving skin condition comprising blueberry and black rice extract fermented lactic acid bacteria
KR102212343B1 (en) Composition for skin anti-aging or moisturization comprising extract of marian plum
JP3938693B2 (en) Collagen production promoter, skin cosmetics and cosmetics
KR102032830B1 (en) Fuctional food improving skin condition comprising rice bran extract
JP3935360B2 (en) Hyaluronic acid production promoter, skin cosmetics and cosmetics
KR20170025363A (en) Composition for improving skin

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070614

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20070614

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20071214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100921

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101130

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110215

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110223

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140304

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4693963

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term